The Fenlix Motor: A Validated Computational Pipeline for Kinase Inhibitor Selectivity Prediction — Four Disease Cases, One Geometric Principle
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Four diseases. Four candidates. One principle. The Fenlix Motor — a three-stage computational pipeline for kinase inhibitor selectivity prediction — has identified minimal structural modifications that produce consistent selectivity improvements across four independent disease targets: pancreatic cancer (KRAS G12D), Chagas disease (TcCLK1), antiarrhythmic toxicity reduction (DYRK1B), and autism spectrum disorder (DYRK1A/CDK5). The pattern that emerges is geometric: in three of four cases, a functional group at the meta (3) position of the distal aromatic ring reaches non-conserved hinge residues at the optimal distance (4.0–4.5 Å) for productive non-covalent interactions. The ortho position is sterically blocked. The para position reaches solvent. The meta position reaches the hinge. Four candidates identified: B02_3F (1.34×), E02_3NH2 (1.24×), A01_2Br (1.23×), B01_noEt (1.25×). Each differs from its reference compound by one atom or one functional group. Each prediction is crystallographically anchored in RCSB PDB structures. The complete pipeline runs on accessible mobile hardware at zero cost. No institutional infrastructure required. Academic use: unrestricted. Commercial use: written authorization required. Contact: apirolo@abc.gob.ar
Fields of Study & Subjects
Computational Drug Discovery Methods
Protein Degradation and Inhibitors
Protein Kinase Regulation and GTPase Signaling
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 March 2026
- Language
- EN
- Document type
- Preprint